Business
IRADIMED CORPORATION Announces the Appointment of Lynn Neuhardt as Vice President of Research and Development
WINTER SPRINGS, Fla., March 12, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced the appointment of Lynn Neuhardt as Vice President of
About this update from Iradimed Corporation
[{"type":"text","content":"WINTER SPRINGS, Fla., March 12, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced the appointment of Lynn Neuhardt as Vice President of Research and Development, effective March 26, 2020. Mr. Neuhardt will report to Leslie McDonnell, President and Chief Executive Officer.\n “Lynn is an experienced R&D leader with deep knowledge in the development of IV infusion pumps. Lynn will lead our talented R&D team and collaborate closely with Roger Susi, our founder and Chief Technology Officer. I am confident his leadership and direct contributions to our current and future products will help drive our continued success. We are excited to add him to the executive team,” said McDonnell. About Lynn Neuhardt Mr. Neuhardt has extensive experience in the medical technology industry and specifically with IV infusion pumps. Prior to his appointment at IRADIMED, Mr. Neuhardt spent 4 years at ICU Medical, Inc. as a Director of Systems and Test Engineering. Prior to that, Mr. Neuhardt spent over 14 years at Hospira, Inc. the former hospital products division of Abbott Laboratories, where he held various hardware and software design, development and testing engineering roles of increasing responsibility. Mr. Neuhardt is experienced in the development of IV infusion pumps and in all phases of new product development. He earned a Bachelor of Science Degree in Electrical Engineering Technology from the University of Minnesota. About IRADIMED CORPORATION IRADIMED CORPORATION is a leader in the development of innovative magnetic resonance imaging (“MRI”) compatible medical devices. We are the only known provider of a non-magnetic intravenous (“IV”) infusion pump system that is specifically designed to be safe for use during MRI procedures. We were the first to develop an infusion delivery system that largely eliminates many of the dangers and problems present during MRI procedures. Standard infusion pumps contain magnetic and electronic components which can create radio frequency interference and are dangerous to operate in the presence of the powerful magnet that drives an MRI system. Our patented MRidium® MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor, uniquely designed non-ferrous parts and other special features to safely and predictably deliver anesthesia and other IV fluids during...